INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $527,000 | +235.7% | 100,000 | +400.0% | 0.05% | +283.3% |
| Q4 2015 | $157,000 | -53.6% | 20,000 | -50.0% | 0.01% | -14.3% |
| Q3 2015 | $338,000 | -24.7% | 40,000 | -2.4% | 0.01% | -48.1% |
| Q2 2015 | $449,000 | -47.4% | 41,000 | -32.8% | 0.03% | -59.1% |
| Q1 2015 | $853,000 | +229.3% | 61,000 | +298.1% | 0.07% | +200.0% |
| Q4 2014 | $259,000 | -94.6% | 15,323 | -95.6% | 0.02% | -96.2% |
| Q4 2013 | $4,834,000 | -29.0% | 350,000 | -10.3% | 0.58% | +107.5% |
| Q3 2013 | $6,804,000 | +275.3% | 390,310 | +248.7% | 0.28% | +53.0% |
| Q2 2013 | $1,813,000 | – | 111,940 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |